What is a limitation of screening immunoassays in toxicology?

Prepare for the Clinical Chemistry and Pathologic of Biochemistry Exam with comprehensive questions, detailed explanations, and effective study strategies. Ace your test with confidence!

Multiple Choice

What is a limitation of screening immunoassays in toxicology?

Screening immunoassays in toxicology are limited by cross-reactivity, where antibodies designed to detect a specific drug or drug class can also bind structurally related compounds. This binding can trigger a positive signal even when the target substance is absent, leading to false positives. Because of this, immunoassay results are considered preliminary and require confirmation with a more specific method, such as GC-MS or LC-MS/MS, to determine the exact compound present. Immunoassays are fast, inexpensive, and good for high-throughput screening, but they sacrifice specificity compared with chromatographic methods.

Screening immunoassays in toxicology are limited by cross-reactivity, where antibodies designed to detect a specific drug or drug class can also bind structurally related compounds. This binding can trigger a positive signal even when the target substance is absent, leading to false positives. Because of this, immunoassay results are considered preliminary and require confirmation with a more specific method, such as GC-MS or LC-MS/MS, to determine the exact compound present. Immunoassays are fast, inexpensive, and good for high-throughput screening, but they sacrifice specificity compared with chromatographic methods.

More practice questions